[HTML][HTML] T cell responses to SARS-CoV-2 spike cross-recognize Omicron
…, Z de Beer, TR de Villiers, A Bodenstein… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
…, Z de Beer, TR de Villiers, A Bodenstein… - MedRxiv, 2021 - medrxiv.org
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that contribute to
escape from the neutralizing antibody responses, and reducing vaccine protection from …
escape from the neutralizing antibody responses, and reducing vaccine protection from …
[PDF][PDF] SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
…, H Tegally, Z de Beer, TR de Villiers, A Bodenstein… - Cell Host & Microbe, 2022 - cell.com
The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by vaccines or
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
infection. However, whether Omicron triggers cross-reactive humoral responses to other …
[PDF][PDF] Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
…, SR Balla, Z de Beer, TR de Villiers, A Bodenstein… - Cell Reports …, 2023 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4 and BA.5
variants caused major waves of infections. Here, we assess the sensitivity of BA.4 to …
variants caused major waves of infections. Here, we assess the sensitivity of BA.4 to …
SARS-CoV-2 BA. 4 infection triggers more cross-reactive neutralizing antibodies than BA. 1
…, N Wolter, Z de Beer, TR de Villiers, A Bodenstein… - bioRxiv, 2022 - biorxiv.org
SARS-CoV-2 variants of concern (VOCs) differentially trigger neutralizing antibodies with
variable cross-neutralizing capacity. Here we show that unlike SARS-CoV-2 Omicron BA.1, …
variable cross-neutralizing capacity. Here we show that unlike SARS-CoV-2 Omicron BA.1, …
Fc effector activity and neutralization against SARS-CoV-2 BA. 4 is compromised in convalescent sera, regardless of the infecting variant
…, T Hermanus, Z de Beer, TR de Villiers, A Bodenstein… - bioRxiv, 2022 - biorxiv.org
The SARS-CoV-2 Omicron BA.1 variant, which exhibits high level neutralization resistance,
has since evolved into several sub-lineages including BA.4 and BA.5, which have dominated …
has since evolved into several sub-lineages including BA.4 and BA.5, which have dominated …
Safety of a second homologous Ad26. COV2. S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa
A Takalani, M Robinson, P Jonas, A Bodenstein… - Vaccine, 2024 - Elsevier
The Sisonke 2 study provided a homologous boost at least 6 months after administration of
the priming dose of Ad26.COV2.S for healthcare workers enrolled on the Sisonke phase 3b …
the priming dose of Ad26.COV2.S for healthcare workers enrolled on the Sisonke phase 3b …
Author correction: T cell responses to SARS-CoV-2 spike cross-recognize omicron
…, Z de Beer, TR de Villiers, A Bodenstein… - Nature, 2022 - ncbi.nlm.nih.gov
… de Villiers, 9 Annie Bodenstein, 9 Gretha van den Berg, 9 Adriano Mendes, 10 Amy
Strydom, 10 Marietjie Venter, 10 Jennifer Giandhari, 11 Yeshnee Naidoo, 11 Sureshnee Pillay …
Strydom, 10 Marietjie Venter, 10 Jennifer Giandhari, 11 Yeshnee Naidoo, 11 Sureshnee Pillay …
SARS-CoV-2 BA. 4 infection triggers more cross-reactive neutralizing antibodies than BA. 1 (preprint)
…, N Wolter, Z de Beer, TR de Villiers, A Bodenstein… - 2022 - pesquisa.bvsalud.org
SARS-CoV-2 variants of concern (VOCs) differentially trigger neutralizing antibodies with
variable cross-neutralizing capacity. Here we show that unlike SARS-CoV-2 Omicron BA. 1, …
variable cross-neutralizing capacity. Here we show that unlike SARS-CoV-2 Omicron BA. 1, …
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron (preprint)
…, Z de Beer, TR de Villiers, A Bodenstein… - 2021 - pesquisa.bvsalud.org
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that contribute to
escape from the neutralizing antibody responses, and reducing vaccine protection from …
escape from the neutralizing antibody responses, and reducing vaccine protection from …